Michigan Attorney General Dana Nessel plans to investigate Eli Lilly's insulin pricing but will have to first overturn Michigan court precedent in order to push forward with the probe.
The investigation into sky-high insulin prices is being blocked by Michigan Supreme Court opinions that prohibit the Attorney General's Office from investigating an entity under the Michigan Consumer Protection Act if that entity is already regulated by a state or federal agency.
In Eli Lilly's case, the entity is regulated by both the Federal Drug Administration and the Michigan Board of Pharmacy — neither of which have much authority over pricing.
